Status:
WITHDRAWN
Interest of Indocyanine Green in Neoplastic Prostatic Tissue
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Phase:
PHASE3
Brief Summary
Prostate cancer, with more than 70,000 new cases and 8900 deaths a year in France, is a major public health problem. Until 28% of patients treated with surgery will present a positive surgical margin ...
Detailed Description
The ability of ICG to detect a surgical margin positive intraoperatively has never be evaluated. We want to perform a monocentric prospective ex-vivo pilot in order to evaluate the diagnostic performa...
Eligibility Criteria
Inclusion
- Patients with prostatic cancer proved by biopsy and needing total prostatectomy with or without curettage.
- Patient affiliated to a social security scheme
- Patient has given its informed consent
Exclusion
- contra-indication to surgery
- non confirmed adenocarcinoma diagnostic
- antecedent of prostatic cancer treatment
- antecedent of pelvic surgery
Key Trial Info
Start Date :
April 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02260349
Start Date
April 1 2014
End Date
February 1 2016
Last Update
March 10 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.